SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is facing intense volatility as traders debate whether the recent sharp price decline represents a long-term cyclical top or a strategic buying opportunity driven by record memory demand. The community is heavily focused on upcoming industry earnings reports and a major international listing as catalysts that could validate the ongoing AI infrastructure supercycle.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as investors react to volatility surrounding its correlation with South Korean semiconductor peers, specifically ahead of Samsung's highly anticipated earnings guidance. While community sentiment is divided between those bracing for a deeper pullback and others viewing the dip as a prime opportunity to buy into a long-term AI memory supercycle.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is seeing a significant surge in trading volume and renewed investor attention, fueled by its recent inclusion in the Russell 3000 index and ongoing speculation regarding potential partnerships aimed at modernizing the real estate sector. The community remains divided, with bulls pointing to technical momentum and long-term industry disruption potential, while bears continue to highlight historical price volatility and the persistent challenges of the company's asset-heavy business model.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending after reporting Q2 production and delivery figures that exceeded analyst estimates, prompting the company to raise its full-year delivery guidance. While the stock saw significant upward momentum driven by this operational progress and expectations for the upcoming R2 model, community members are actively debating the sustainability of this rally versus potential volatility from short interest and broader sector dynamics.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending following a transformational deal with Anthropic, involving a 20-year lease for a data center campus that represents a major strategic pivot toward long-term AI infrastructure revenue. Community sentiment is deeply divided, with many investors highlighting the deal as a generational valuation catalyst while others express frustration over the stock's volatile price action and ongoing concerns regarding institutional manipulation and short selling.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is generating significant community interest as investors weigh its shift toward a leaner R&D model alongside long-standing buyout rumors. The recent closure of its internal discovery facility and positive clinical data presentations are fueling active debates over whether the company is positioning itself as a more attractive acquisition target or focusing on sustainable internal growth.

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The firm's product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. It is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals is trending after Vertex Pharmaceuticals announced a $10 billion cash acquisition of the company, representing a significant premium and a major expansion into the endocrinology sector. The community is actively discussing the successful exit for long-term investors, the strategic value of the lead asset for acromegaly, and potential implications for biotech M&A activity.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv is trending as large banks, including JPMorgan Chase and Bank of America, have held preliminary discussions to acquire a portion of the company's debit network. Investors are actively debating the potential impact of this deal on the company's valuation, with many discussing the prospects of a buyout and the stock's significant move in recent trading sessions.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The VanEck Semiconductor ETF (SMH) is trending as investors grapple with extreme sector concentration and rotation, with many debating whether the current strength represents a structural AI-driven supercycle or a late-stage parabolic bubble vulnerable to a sharp pullback. Community discussion is heavily focused on the disconnect between soaring valuations and broader market participation, with traders closely monitoring Microns upcoming earnings and global chip liquidity as pivotal signals for the next trend.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

T-Mobile US is capturing investor attention following a combination of a strategic Buy upgrade from Bank of America and ongoing market discussions regarding the company's competitive positioning against LEO satellite broadband. Investors are actively debating the potential for long-term integration between terrestrial wireless networks and emerging satellite connectivity, with many highlighting T-Mobile's metropolitan footprint as a key factor in its resilience.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rivian Automotive, Tenax Therapeutics, Robinhood And Other Big Stocks Moving Higher On Thursday

Rivian Automotive Inc (RIVN) gained 12.2% after strong Q2 production figures and raised delivery forecast. Other companies such as Nexa Resources SA (NEXA) and Moderna Inc (MRNA) also saw gains in today's session.read more...

Tenax Therapeutics, Inc. (NASDAQ:TENX) Given Consensus Rating of "Moderate Buy" by Brokerages

Shares of Tenax Therapeutics, Inc. (NASDAQ:TENX - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the six research firms that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have assigned a buy...

Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above Two Hundred Day Moving Average   - Should You Sell?

Tenax Therapeutics (NASDAQ:TENX) Shares Pass Above 200-Day Moving Average - What's Next...

Tenax Therapeutics, Inc. (NASDAQ:TENX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Tenax Therapeutics, Inc. (NASDAQ:TENX - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six ratings firms that are covering the firm, Marketbeat.com reports. One equities...

Tenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above 200-Day Moving Average - What's Next?

Tenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above 200-Day Moving Average - What's Next...

Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above Two Hundred Day Moving Average   - What's Next?

Tenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above Two Hundred Day Moving Average - Should You Sell...

Cantor Fitzgerald Initiates Coverage on Tenax Therapeutics (NASDAQ:TENX)

Cantor Fitzgerald began coverage on shares of Tenax Therapeutics in a research report on Tuesday. They set an "overweight" rating and a $35.00 target price on the stock...

Boothbay Fund Management LLC Purchases Shares of 352,206 Tenax Therapeutics, Inc. $TENX

Boothbay Fund Management LLC acquired a new position in shares of Tenax Therapeutics, Inc. (NASDAQ:TENX - Free Report) in the third quarter, according to its most recent Form 13F filing with the...

Tenax Therapeutics (TENX) Expected to Announce Quarterly Earnings on Tuesday

Tenax Therapeutics (NASDAQ:TENX) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 24. (View Earnings Report at...

Guggenheim Issues Positive Forecast for Tenax Therapeutics (NASDAQ:TENX) Stock Price

Guggenheim raised their price target on shares of Tenax Therapeutics from $25.00 to $34.00 and gave the stock a "buy" rating in a report on Monday...

Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company was founded on May 26, 1967 and is headquartered in Chapel Hill, NC.

Tenax Therapeutics Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$16.26
Prev Close	$15.46
Open	$15.47
Dividend Yield	0.00%
50-Day Moving Average	$12.38
Beta	0.51
Avg. Volume	1.23M
PE Ratio	-11.62

52-Week High	$18.38
52-Week Low	$5.68
Market Capitalization	$410.08M
EPS (Annual)	-$1.34
Price to Book	3.44
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

TENXTenax Therapeutics Inc

Latest TENX News